Chemed (CHE) Non-Current Deferred Tax Liability (2009 - 2026)

Chemed (CHE) has reported Non-Current Deferred Tax Liability for 18 consecutive years, with $14.6 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Non-Current Deferred Tax Liability rose 23.82% year-over-year to $14.6 million; the TTM figure through Mar 2026 stood at $14.6 million (up 23.82% YoY), while the FY2025 annual figure was $19.3 million, down 25.56% from the prior year.
• Non-Current Deferred Tax Liability came in at $14.6 million for Q1 2026 at Chemed, down from $19.3 million in the prior quarter.
• The five-year high for Non-Current Deferred Tax Liability was $38.6 million in Q4 2022, with the low at $9.7 million in Q3 2025.
• Average Non-Current Deferred Tax Liability over 5 years is $24.7 million, with a median of $25.9 million recorded in 2024.
• Across the five-year window, Non-Current Deferred Tax Liability jumped 85.09% in 2023 and sank 65.5% in 2025, its largest moves.
• Year by year, Non-Current Deferred Tax Liability stood at $38.6 million in 2022, then retreated by 21.47% to $30.3 million in 2023, then retreated by 14.43% to $25.9 million in 2024, then decreased by 25.56% to $19.3 million in 2025, then dropped by 24.53% to $14.6 million in 2026.
• According to Business Quant data, Non-Current Deferred Tax Liability over the past three periods registered $14.6 million, $19.3 million, and $9.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.